Table 1.
Demographic characteristics and pulmonary function test results of the study groups
Disease | (n) | Age (range) | Sex (F/M) | FEV (%) | DLCO (%) | TLC (%) |
---|---|---|---|---|---|---|
Crohns disease (CRD) | (18) | 22–80 | 9/9 | 97·6 ± 18·7 | 94 ± 15·8 | 92 ± 23·8 |
Sarcoidosis (SA) | (13) | 46–68 | 6/7 | 80·5 ± 24·2* | 79·4 ± 12·9† | 92·8 ± 27·8 |
Controls (CO) | (9) | 20–60 | 3/6 | 96·2 ± 6·9 | ND | 99 ± 10·6 |
FEV1, flow expiratory volume in one second; DLCO, diffusion lung carbon monoxide; TLC, total lung capacity – percent prediction; ND, not done.
P = 0·03 FEV1 CD versus SA and 0·037 SA versus C0
P = 0·007 DLCO SA versus CRD.